Patients taking angiotensin-converting enzyme inhibitors/angiotensin II type I receptor blockers: higher risks of severe acute respiratory syndrome coronavirus 2 infection but milder clinical manifestations?
10.1097/CM9.0000000000000996
- Author:
Jie-Lin DENG
1
;
Yun-Qiu JIANG
2
;
Yan-Kai GUO
1
;
Hong-Liang LI
2
Author Information
1. Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei 430060, China.
2. Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73117, USA.
- Publication Type:Editorial
- MeSH:
Angiotensin II Type 1 Receptor Blockers/adverse effects*;
Angiotensin-Converting Enzyme 2;
Angiotensin-Converting Enzyme Inhibitors/adverse effects*;
Betacoronavirus;
COVID-19;
Coronavirus Infections/etiology*;
Humans;
Pandemics;
Peptidyl-Dipeptidase A/physiology*;
Pneumonia, Viral/etiology*;
SARS-CoV-2
- From:
Chinese Medical Journal
2020;133(22):2650-2652
- CountryChina
- Language:English